the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM
Official Title A Phase 2 Single-arm Study to Evaluate Safety and Efficacy of CRS-207 With Pembrolizumab in Adults With Previously-Treated Malignant Pleural Mesothelioma
Principal Investigator Kindler, Hedy
Brief Summary The purpose of this study is to evaluate whether CRS-207 with pembrolizumab is safe and effective in adults with MPM who have failed prior anti-cancer therapy.
Gender All
Ages 18 Years
Enrollment 35
Accepts Healthy Volunteers No
Lead Sponsor Aduro Biotech, Inc.Industry
Collaborator Merck Sharp & Dohme Corp.Industry
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name Thierry M Jahan, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Malignant Pleural Mesothelioma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI